Skip to content

Insider · CIK 0001775281

TITUS BRIAN

officer

Files at CTVA (Corteva, Inc.). First filing Feb 24, 2025, latest Feb 24, 2025.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 1
$0 bought, $1.7M sold

Signals

This insider’s open-market buys and sells, scored.

ScoreSideCompanyValueSharesHoldings changePrice contextFiled
53Moderatesell 2CTVA
Corteva, Inc.
$1.7M26,560-70%-

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Feb 28, 2025CTVA
Corteva, Inc.
FTax withholding
Common Stock
-106$62.98$6,67611,241Mar 4, 2025
Feb 20, 2025CTVA
Corteva, Inc.
FTax withholding
Common Stock
-126$63.83$8,04316,347Feb 24, 2025
Feb 20, 2025CTVA
Corteva, Inc.
MOption exercise
Common Stock
+12,142$31.22$379k28,489Feb 24, 2025
Feb 20, 2025CTVA
Corteva, Inc.
MOption exercise
Common Stock
+9,418$45.15$425k37,907Feb 24, 2025
Feb 20, 2025CTVA
Corteva, Inc.
SOpen-market sale
Common Stock
-26,560$63.74$1.7M11,347Feb 24, 2025
Feb 20, 2025CTVA
Corteva, Inc.
MOption exercise
Non-Qualified Stock Option (right-to-buy)derivative
-12,142$0.00$00Feb 24, 2025
Feb 20, 2025CTVA
Corteva, Inc.
MOption exercise
Non-Qualified Stock Option (right-to-buy)derivative
-9,418$0.00$00Feb 24, 2025
Feb 18, 2025CTVA
Corteva, Inc.
FTax withholding
Common Stock
-132$64.46$8,50915,464Feb 20, 2025
Feb 18, 2025CTVA
Corteva, Inc.
AGrant or award
Common Stock
+1,009$0.00$016,473Feb 20, 2025
Feb 18, 2025CTVA
Corteva, Inc.
AGrant or award
Non-Qualified Stock Option (right-to-buy)derivative
+2,730$0.00$02,730Feb 20, 2025
Jan 24, 2025CTVA
Corteva, Inc.
AGrant or award
Common Stock
+3,231$0.00$016,746Jan 28, 2025
Jan 24, 2025CTVA
Corteva, Inc.
FTax withholding
Common Stock
-1,150$63.96$74k15,596Jan 28, 2025

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

TITUS BRIAN: insider trades and track record | InsiderTell